Yui Shibayama

Sapporo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Switching from Conventional Fibrates to Pemafibrate Has Beneficial Effects on the Renal Function of Diabetic Subjects with Chronic Kidney Disease.

Switching from Conventional Fibrates to Pemafibrate Has Beneficial Effects on the Renal Function of Diabetic Subjects with Chronic Kidney Disease.

Journal: Diabetes & metabolism journal

Published: October 15, 2023

Identifying primary aldosteronism patients who require adrenal venous sampling: a multi-center study.

Identifying primary aldosteronism patients who require adrenal venous sampling: a multi-center study.

Journal: Scientific reports

Published: March 29, 2023

Class 3 PI3K coactivates the circadian clock to promote rhythmic de novo purine synthesis.

Class 3 PI3K coactivates the circadian clock to promote rhythmic de novo purine synthesis.

Journal: Nature cell biology

Published: May 30, 2022

Class 3 phosphoinositide 3-kinase promotes hepatic glucocorticoid receptor stability and transcriptional activity.

Class 3 phosphoinositide 3-kinase promotes hepatic glucocorticoid receptor stability and transcriptional activity.

Journal: Acta physiologica (Oxford, England)

Published: November 09, 2021

Prediction of unilateral hyperaldosteronism on adrenal vein sampling using captopril challenge test in patients with primary aldosteronism.

Prediction of unilateral hyperaldosteronism on adrenal vein sampling using captopril challenge test in patients with primary aldosteronism.

Journal: Endocrine journal

Published: August 28, 2020

The risk factors for hepatic steatosis in patients with primary aldosteronism.

The risk factors for hepatic steatosis in patients with primary aldosteronism.

Journal: Endocrine journal

Published: March 28, 2020

Sodium-glucose cotransporter 2 inhibitors reduce day-to-day glucose variability in patients with type 1 diabetes.

Sodium-glucose cotransporter 2 inhibitors reduce day-to-day glucose variability in patients with type 1 diabetes.

Journal: Journal of diabetes investigation

Published: March 19, 2020

Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism.

Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism.

Journal: Journal of hypertension

Published: May 31, 2019

Influence of antihypertensive drugs in the subtype diagnosis of primary aldosteronism by adrenal venous sampling.

Influence of antihypertensive drugs in the subtype diagnosis of primary aldosteronism by adrenal venous sampling.

Journal: Journal of hypertension

Published: April 30, 2019

Lateralizing Asymmetry of Adrenal Imaging and Adrenal Vein Sampling in Patients With Primary Aldosteronism.

Lateralizing Asymmetry of Adrenal Imaging and Adrenal Vein Sampling in Patients With Primary Aldosteronism.

Journal: Journal of the Endocrine Society

Published: April 03, 2019

Case of fulminant type 1 diabetes induced by the anti-programmed death-ligand 1 antibody, avelumab.

Case of fulminant type 1 diabetes induced by the anti-programmed death-ligand 1 antibody, avelumab.

Journal: Journal of diabetes investigation

Published: January 08, 2019

Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan.

Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan.

Journal: Journal of human hypertension

Published: August 18, 2018

Showing 1-12 of 23

Last Updated: 09/26/2026